Literature DB >> 19190808

Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP).

Kerstin Benz1, Kerstin Amann.   

Abstract

In this paper, epidemiology, pathogenesis and typical morphological aspects of all three types of membranoproliferative glomerulonephritis (MPGN), of the haemolytic uraemic syndrome (HUS) as well as of thrombotic thrombopenic purpura (TTP) will be reviewed on the light microscopical, immunohistological or immunofluorescence and electron microscopical level. In particular, differences in the pathogenesis of these diseases are discussed. Important recent molecular and genetic insights into the pathogenesis of the three types of MPGN, of typical and atypical HUS and of TTP, i.e. dysregulation of the complement system, distinct molecular defects in C3 and factor H, the major regulatory protein of the alternative pathway of complement activation, and deficiency of a von Willebrand factor (VWF) -cleaving protease, i.e. ADAMTS13, are highlighted. Finally, particular emphasis will be put on differences in glomerular and vascular morphology in the three types of MPGN and in thrombotic microangiopathy (TMA), which is the characteristic morphological alteration of the kidney in HUS and TTP, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190808

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

Review 1.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

2.  Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.

Authors:  Ansgar Reising; Carsten Hafer; Marcus Hiss; Jan T Kielstein; Jan Menne; Faikah Gueler; Jan Beneke; Silvia Linnenweber-Held; Hermann Haller; Gunilla Einecke
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

3.  Trends in pediatric primary membranoproliferative glomerulonephritis costs and complications.

Authors:  Chang-Ching Wei; Wei Wang; William E Smoyer; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-07-18       Impact factor: 3.714

Review 4.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy.

Authors:  Ramesh Tati; Ann-Charlotte Kristoffersson; Anne-Lie Ståhl; Johan Rebetz; Li Wang; Christoph Licht; David Motto; Diana Karpman
Journal:  J Immunol       Date:  2013-07-22       Impact factor: 5.422

Review 6.  Defective complement inhibitory function predisposes to renal disease.

Authors:  Anuja Java; John Atkinson; Jane Salmon
Journal:  Annu Rev Med       Date:  2012-11-01       Impact factor: 13.739

Review 7.  Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.

Authors:  Lindsay Keir; Richard J M Coward
Journal:  Pediatr Nephrol       Date:  2010-10-15       Impact factor: 3.714

Review 8.  Inherited Kidney Complement Diseases.

Authors:  Mathieu Lemaire; Damien Noone; Anne-Laure Lapeyraque; Christoph Licht; Véronique Frémeaux-Bacchi
Journal:  Clin J Am Soc Nephrol       Date:  2021-02-03       Impact factor: 10.614

9.  Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.

Authors:  Ramesh Tati; Ann-Charlotte Kristoffersson; Minola Manea Hedström; Matthias Mörgelin; Jörgen Wieslander; Cees van Kooten; Diana Karpman
Journal:  EBioMedicine       Date:  2017-01-24       Impact factor: 8.143

10.  Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.

Authors:  Olivia May; Nicolas S Merle; Anne Grunenwald; Viviane Gnemmi; Juliette Leon; Cloé Payet; Tania Robe-Rybkine; Romain Paule; Florian Delguste; Simon C Satchell; Peter W Mathieson; Marc Hazzan; Eric Boulanger; Jordan D Dimitrov; Veronique Fremeaux-Bacchi; Marie Frimat; Lubka T Roumenina
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.